Literature DB >> 10868499

The insulin-like growth factor system: basic and clinical aspects.

L A Bach1.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10868499     DOI: 10.1111/j.1445-5994.1999.tb00719.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


× No keyword cloud information.
  5 in total

1.  Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.

Authors:  Paul Gregorevic; David R Plant; Kerri S Leeding; Leon A Bach; Gordon S Lynch
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  The insulin-like growth factor system: towards clinical applications.

Authors:  Leon A Bach
Journal:  Clin Biochem Rev       Date:  2004-08

3.  Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice.

Authors:  Jonathan D Schertzer; Stefan M Gehrig; James G Ryall; Gordon S Lynch
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

4.  Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading.

Authors:  Reiko Nakao; Katsuya Hirasaka; Jumpei Goto; Kazumi Ishidoh; Chiharu Yamada; Ayako Ohno; Yuushi Okumura; Ikuya Nonaka; Koji Yasutomo; Kenneth M Baldwin; Eiki Kominami; Akira Higashibata; Keisuke Nagano; Keiji Tanaka; Natsuo Yasui; Edward M Mills; Shin'ichi Takeda; Takeshi Nikawa
Journal:  Mol Cell Biol       Date:  2009-06-22       Impact factor: 4.272

5.  Effect of vitronectin bound to insulin-like growth factor-I and insulin-like growth factor binding protein-3 on porcine enamel organ-derived epithelial cells.

Authors:  Yoshinori Shinohara; Shuhei Tsuchiya; Kazuo Hatae; Masaki J Honda
Journal:  Int J Dent       Date:  2012-04-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.